Cooler Heads Care has filed a notice of an exempt offering of securities to raise $5,999,928.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Cooler Heads Care is raising up to $5,999,928.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Cooler Heads Care
Cooler Heads Care is a San Diego-based medical device company founded in 2018 by tech entrepreneur and breast cancer survivor Kate Dilligan. The company focuses on helping cancer patients manage chemotherapy side effects, especially hair loss, through its FDA-cleared Amma scalp cooling system. Amma is designed as a user-friendly, portable alternative to traditional cold caps and is intended to help patients preserve their hair, dignity, and sense of control during treatment. The system cools the scalp before, during, and after chemotherapy to reduce the amount of chemotherapy reaching hair follicles, and it is described on the site as a solution for adult patients with solid tumors. Cooler Heads presents itself as an evidence-based company dedicated to making scalp cooling more affordable, comfortable, and accessible for patients undergoing chemotherapy.
To learn more, visit https://www.coolerheads.com/
LinkedIn: https://www.linkedin.com/company/cooler-heads-technology
Contact:
Kathleen Dilligan, Chief Executive Officer
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.